{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:11:30Z","timestamp":1784265090300,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008853","name":"Jining Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.brainresbull.2021.03.018","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T22:41:56Z","timestamp":1617230516000},"page":"142-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The TAAR1 inhibitor EPPTB suppresses neuronal excitability and seizure activity in mice"],"prefix":"10.1016","volume":"171","author":[{"given":"Qingxia","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.brainresbull.2021.03.018_bib0005","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1523\/JNEUROSCI.1312-15.2015","article-title":"Modulation by trace amine-associated receptor 1 of experimental parkinsonism, L-DOPA responsivity, and glutamatergic neurotransmission","volume":"35","author":"Alvarsson","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.brainresbull.2021.03.018_bib0010","doi-asserted-by":"crossref","first-page":"13901","DOI":"10.1038\/s41598-017-14472-z","article-title":"Interaction between the trace amine-associated receptor 1 and the dopamine D2 receptor controls cocaine\u2019s neurochemical actions","volume":"7","author":"Asif-Malik","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.brainresbull.2021.03.018_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157488707779318107","article-title":"The potential of trace amines and their receptors for treating neurological and psychiatric diseases","volume":"2","author":"Berry","year":"2007","journal-title":"Rev. Recent Clin. Trials"},{"issue":"1","key":"10.1016\/j.brainresbull.2021.03.018_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug discovery"},{"issue":"9","key":"10.1016\/j.brainresbull.2021.03.018_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.biopsych.2016.10.012","article-title":"Trace amine-associated receptor 1 agonists as narcolepsy therapeutics","volume":"82","author":"Black","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"16","key":"10.1016\/j.brainresbull.2021.03.018_bib0030","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.brainresbull.2021.03.018_bib0035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4522(98)00401-1","article-title":"Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy","volume":"89","author":"Bouilleret","year":"1999","journal-title":"Neuroscience"},{"issue":"47","key":"10.1016\/j.brainresbull.2021.03.018_bib0040","doi-asserted-by":"crossref","first-page":"20081","DOI":"10.1073\/pnas.0906522106","article-title":"The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system","volume":"106","author":"Bradaia","year":"2009","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.brainresbull.2021.03.018_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1471-4892(02)00028-0","article-title":"Trace amine receptors as targets for novel therapeutics: legend, myth and fact","volume":"3","author":"Branchek","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6","key":"10.1016\/j.brainresbull.2021.03.018_bib0050","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2021.03.018_bib0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.neuropharm.2014.06.011","article-title":"Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes","volume":"85","author":"Cisneros","year":"2014","journal-title":"Neuropharmacology"},{"issue":"4-6","key":"10.1016\/j.brainresbull.2021.03.018_bib0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0278-5846(83)90067-2","article-title":"Pharmacology of beta-phenylethylamine-induced seizures in mice","volume":"7","author":"Dourish","year":"1983","journal-title":"Progress Neuro-psychopharmacol. Biol. Psych."},{"key":"10.1016\/j.brainresbull.2021.03.018_bib0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2015.02.010","article-title":"Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1","volume":"93","author":"Espinoza","year":"2015","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.brainresbull.2021.03.018_bib0070","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/npp.2015.65","article-title":"TAAR1 modulates cortical glutamate NMDA receptor function","volume":"40","author":"Espinoza","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.brainresbull.2021.03.018_bib0075","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/npp.2016.233","article-title":"The trace amine-associated receptor 1 agonist RO5256390 blocks compulsive, binge-like eating in rats","volume":"42","author":"Ferragud","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.brainresbull.2021.03.018_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","article-title":"Refractory epilepsy: clinical overview","volume":"48","author":"French","year":"2007","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.brainresbull.2021.03.018_bib0085","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.euroneuro.2015.08.011","article-title":"Trace amine-associated receptor 1 activation silences GSK3beta signaling of TAAR1 and D2R heteromers","volume":"25","author":"Harmeier","year":"2015","journal-title":"Europe. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2021.03.018_bib0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.schres.2017.02.020","article-title":"Possible role of rare variants in trace amine associated receptor 1 in schizophrenia","volume":"189","author":"John","year":"2017","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.brainresbull.2021.03.018_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2014.02.007","article-title":"Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors","volume":"81","author":"Leo","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainresbull.2021.03.018_bib0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygeno.2004.11.010","article-title":"Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors","volume":"85","author":"Lindemann","year":"2005","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.brainresbull.2021.03.018_bib0105","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1523\/JNEUROSCI.2006-16.2016","article-title":"Role of TAAR1 within the subregions of the mesocorticolimbic dopaminergic system in cocaine-seeking behavior","volume":"37","author":"Liu","year":"2017","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.brainresbull.2021.03.018_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"Loscher","year":"1988","journal-title":"Epilepsy Res."},{"issue":"10","key":"10.1016\/j.brainresbull.2021.03.018_bib0115","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/npp.2014.88","article-title":"Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking","volume":"39","author":"Pei","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2021.03.018_bib0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eplepsyres.2015.09.008","article-title":"Pilocarpine-induced status epilepticus in mice: a comparison of spectral analysis of electroencephalogram and behavioral grading using the Racine scale","volume":"117","author":"Phelan","year":"2015","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.brainresbull.2021.03.018_bib0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmet.2015.09.015","article-title":"Incretin-like effects of small molecule trace amine-associated receptor 1 agonists","volume":"5","author":"Raab","year":"2016","journal-title":"Mol. Metabol."},{"issue":"3","key":"10.1016\/j.brainresbull.2021.03.018_bib0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"8","key":"10.1016\/j.brainresbull.2021.03.018_bib0135","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd3478","article-title":"Trends in the exploitation of novel drug targets. Nature reviews","volume":"10","author":"Rask-Andersen","year":"2011","journal-title":"Drug discovery"},{"issue":"11","key":"10.1016\/j.brainresbull.2021.03.018_bib0140","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","article-title":"Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics","volume":"72","author":"Revel","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainresbull.2021.03.018_bib0145","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/mp.2012.57","article-title":"A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight","volume":"18","author":"Revel","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainresbull.2021.03.018_bib0150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11910-007-0053-z","article-title":"The neurobiology of epilepsy","volume":"7","author":"Scharfman","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"6","key":"10.1016\/j.brainresbull.2021.03.018_bib0155","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/npp.2016.216","article-title":"Trace amine-associated receptor 1 regulates wakefulness and EEG spectral composition","volume":"42","author":"Schwartz","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.brainresbull.2021.03.018_bib0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1528-1157.1972.tb04577.x","article-title":"Observations on the relation of migraine and epilepsy. An electroencephalographic, psychological and clinical study using oral tyramine","volume":"13","author":"Scott","year":"1972","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.brainresbull.2021.03.018_bib0165","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/FBP.0000000000000330","article-title":"Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats","volume":"28","author":"Siemian","year":"2017","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainresbull.2021.03.018_bib0170","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bmcl.2010.12.075","article-title":"Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773)","volume":"21","author":"Stalder","year":"2011","journal-title":"Bioorgan. Med. Chem. Lett."},{"issue":"5537","key":"10.1016\/j.brainresbull.2021.03.018_bib0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/258749a0","article-title":"Tyramine activates the EEG in epileptic patients","volume":"258","author":"Swash","year":"1975","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.brainresbull.2021.03.018_bib0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.106.112532","article-title":"Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1","volume":"320","author":"Wainscott","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"10.1016\/j.brainresbull.2021.03.018_bib0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroscience.2015.05.008","article-title":"Effects of JIP3 on epileptic seizures: evidence from temporal lobe epilepsy patients, kainic-induced acute seizures and pentylenetetrazole-induced kindled seizures","volume":"300","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.brainresbull.2021.03.018_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.leukres.2011.10.002","article-title":"Evidence for functional trace amine associated receptor-1 in normal and malignant B cells","volume":"36","author":"Wasik","year":"2012","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.brainresbull.2021.03.018_bib0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.106.117382","article-title":"Trace amine-associated receptor 1 is a modulator of the dopamine transporter","volume":"321","author":"Xie","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"issue":"2","key":"10.1016\/j.brainresbull.2021.03.018_bib0200","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2017.01.157","article-title":"Chronic metformin treatment facilitates seizure termination","volume":"484","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.brainresbull.2021.03.018_bib0205","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1042\/CS20150202","article-title":"Plic-1, a new target in repressing epileptic seizure by regulation of GABAAR function in patients and a rat model of epilepsy","volume":"129","author":"Zhang","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.brainresbull.2021.03.018_bib0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnmol.2017.00100","article-title":"The phosphodiesterase 10A inhibitor PF-2545920 enhances hippocampal excitability and seizure activity involving the upregulation of GluA1 and NR2A in Post-synaptic densities","volume":"10","author":"Zhang","year":"2017","journal-title":"Front. Mol. Neurosci."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923021000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923021000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:45:17Z","timestamp":1759783517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923021000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"alternative-id":["S0361923021000964"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2021.03.018","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TAAR1 inhibitor EPPTB suppresses neuronal excitability and seizure activity in mice","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2021.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}